长非编码RNA DRAIC在癌症进展中的多面性作用
Kouhei Sakurai1, Hiroyasu Ito1
1Department of Joint Research Laboratory of Clinical Medicine, School of Medicine, Fujita Health University, Toyoake, Aichi, 470-1192, Japan.
Life sciences
|March 8, 2024
概括
长非编码RNAs (lncRNAs) 调节了基因. DRAIC lncRNA具有双重作用,在某些癌症中充当瘤抑制剂,在其他癌症中充当促进剂,影响癌症的进展.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 癌症研究 癌症研究
背景情况:
- 长非编码RNAs (lncRNAs) 是关键的基因调节器.
- 异常的lncRNA表达与癌症的开始和进展有关.
- 成千上万的lncRNA与癌症有关,但机制往往不清楚.
研究的目的:
- 审查 lncRNA DRAIC 在癌症进展中的多方面的作用.
- 讨论DRAIC的生物学意义和临床影响.
- 突出DRAIC在各种恶性瘤中的上下文依赖功能.
主要方法:
- 关于DRAIC研究的文献综述.
- 高通量转录组数据的分析.
- 检查DRAIC在生物过程中的监管作用.
主要成果:
- DRAIC最初被确定为前列腺癌中的瘤抑制剂.
- DRAIC在质母细胞瘤,三阴性乳腺癌和胃癌中发挥了抗瘤作用.
- 在肺癌和食道癌症中,DRAIC表现出致癌功能,显示出取决于背景的效应.
结论:
- DRAIC在癌症中扮演着不同的角色,同时作为瘤抑制剂和促进剂.
- DRAIC影响关键的癌症过程,如扩散,入侵,转移,自和神经内分泌功能.
- 了解DRAIC的特定背景功能对于其在癌症治疗中的临床影响至关重要.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
piRNA - Piwi-interacting RNAs
6.9K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.9K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


